S&CO Inc. Boosts Stock Holdings in Roche Holding AG $RHHBY

S&CO Inc. grew its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 163.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,551 shares of the company’s stock after purchasing an additional 87,107 shares during the period. S&CO Inc.’s holdings in Roche were worth $6,880,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Enterprise Financial Services Corp grew its stake in Roche by 6.6% in the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after buying an additional 345 shares in the last quarter. Archer Investment Corp lifted its position in shares of Roche by 7.7% during the first quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock worth $278,000 after acquiring an additional 398 shares in the last quarter. Pinnacle Wealth Management Advisory Group LLC bought a new position in shares of Roche in the first quarter worth $208,000. OLD National Bancorp IN boosted its holdings in shares of Roche by 0.7% in the first quarter. OLD National Bancorp IN now owns 257,854 shares of the company’s stock worth $12,623,000 after acquiring an additional 1,732 shares during the period. Finally, Diversified Trust Co grew its position in shares of Roche by 0.8% in the first quarter. Diversified Trust Co now owns 59,375 shares of the company’s stock valued at $2,907,000 after purchasing an additional 448 shares in the last quarter.

Roche Stock Up 0.3%

Shares of OTCMKTS RHHBY opened at $51.60 on Friday. The stock’s 50-day simple moving average is $51.35 and its two-hundred day simple moving average is $52.68. Roche Holding AG has a twelve month low of $37.51 and a twelve month high of $60.85. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38.

Analyst Ratings Changes

A number of research firms recently issued reports on RHHBY. HSBC lowered Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th. Zacks Research lowered Roche from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 14th. Argus upgraded Roche from a “hold” rating to a “buy” rating in a research report on Monday, April 6th. Finally, Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 price target on the stock in a report on Friday, April 24th. Four investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $51.50.

Roche Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.